ArticleOpen forum infectious diseases2025
Exploring
Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The clinical and epidemiological landscape ofFrontiers in cellular and infection microbiology · 2026Pooled it
- Mycobacterium riyadhense Pulmonary Disease after Relocation from Saudi Arabia, Japan.Emerging infectious diseases · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Methods: We retrospectively analyzed 8 new cases of Results: Pulmonary infections were predominant and frequently mistaken for TB, resulting in diagnostic delays. Extrapulmonary infections included lymphadenitis and osteomyelitis. A novel association with immune complex glomerulonephritis was identified. Molecular sequencing was critical in confirming diagnoses due to limitations in conventional microbiological techniques. Treatment regimens based on macrolides and fluoroquinolones yielded superior therapeutic outcomes, exhibiting lower relapse rates and fewer adverse effects compared with conventional anti-TB therapy. Surgical interventions played a crucial role in managing complicated or refractory cases. Conclusions: Enhancing clinical awareness, employing accurate molecular diagnostic techniques, and adopting targeted antimicrobial therapy are essential for effective management of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.